Interestana
Home/News/Elizabeth Holmes Documentary Stuns Telluride Film Festival
TechCrunch3 min read

By Interestana AI Editorial — AI-drafted, human-overseen. How we report

Elizabeth Holmes Documentary Stuns Telluride Film Festival

A previously unannounced documentary titled "You Can See Everything," focusing on Theranos founder Elizabeth Holmes, premiered at the Telluride Film Festival on Sunday, March 3, 2024. Directed by Nathan Fielder and Lance Oppenheim, the film reportedly granted filmmakers extensive and intimate access to Holmes, who is currently serving a prison sentence for fraud. The documentary's surprise debut and its subject matter generated significant buzz among festival attendees and critics, with early reactions suggesting a candid and potentially revealing portrayal of the disgraced entrepreneur. The film's existence was kept under wraps until its screening, adding to the element of surprise at the prestigious festival. The filmmakers' ability to secure such deep access to Holmes, particularly while she is incarcerated, has been highlighted as a key achievement of the project. This access is expected to provide a unique perspective on Holmes's life, her rise and fall with Theranos, and her experiences within the legal system. The documentary's premiere at Telluride, a festival known for showcasing high-profile and often controversial films, positions it as a significant entry in the genre of biographical documentaries. The film's title, "You Can See Everything," suggests a narrative that aims for complete transparency and insight into Holmes's story. The presence of Nathan Fielder, known for his distinctive comedic and observational style in shows like "The Rehearsal" and "Nathan for You," alongside Lance Oppenheim, whose previous work includes the documentary "Some Kind of Heaven," indicates a potentially unconventional approach to the subject matter. The film's reception at Telluride will likely set the stage for its broader release and critical evaluation. The documentary's focus on Elizabeth Holmes revisits a story that captivated and, in many cases, defrauded the public during the height of Theranos's operations. Theranos, a health technology company, promised revolutionary blood-testing technology that ultimately proved to be fraudulent, leading to Holmes's conviction on multiple counts of wire fraud and conspiracy. The company's valuation had reached $9 billion at its peak, making its collapse one of the most significant corporate scandals of the 21st century. The documentary's exploration of this narrative through direct access to Holmes herself is a notable development in the ongoing public fascination with her story. The Telluride Film Festival, which runs from February 29 to March 5, 2024, is a highly selective event that often serves as a launchpad for films aiming for awards season success. The surprise nature of "You Can See Everything" and its compelling subject matter have already made it a talking point of the festival. The film's success in obtaining such candid access to Holmes is a testament to the filmmakers' efforts and raises questions about the conditions under which this access was granted. The documentary's narrative arc is expected to cover Holmes's early ambitions, the development and eventual exposure of Theranos's fraudulent practices, and her subsequent legal battles and imprisonment. The film's premiere is a significant event for documentary filmmaking and for the continued public interest in the Theranos saga. The filmmakers' ability to capture Holmes's perspective directly is a rare opportunity, offering a potentially definitive account of her side of the story, or at least a deeply personal one. The film's impact will be measured by its ability to offer new insights and provoke thoughtful discussion about ambition, deception, and the consequences of corporate malfeasance. The documentary's screening at Telluride marks its first public exhibition, with further distribution plans anticipated to follow.

Original source — read the full reporting at the publisher:

Read on TechCrunch

Get the weekly AI digest

AI news + new model releases, weekly. Drafted by our agents, reviewed by humans.

Read next